CoChat

Odd skipped-related 1 identifies a population of embryonic fibro-adipogenic progenitors regulating myogenesis during limb development

Open access

The DOI matches its Crossref record; 70 of the 70 references it cites were found in a registry or an index.

Abstract

Fibro-adipogenic progenitors (FAPs) are an interstitial cell population in adult skeletal muscle that support muscle regeneration. During development, interstitial muscle connective tissue (MCT) cells support proper muscle patterning, however the underlying molecular mechanisms are not well understood and it remains unclear whether adult FAPs and embryonic MCT cells share a common lineage. We show here that mouse embryonic limb MCT cells expressing the transcription factor Osr1, differentiate into fibrogenic and adipogenic cells in vivo and in vitro defining an embryonic FAP-like population. Genetic lineage tracing shows that developmental Osr1 + cells give rise to a subset of adult FAPs. Loss of Osr1 function leads to a reduction of myogenic progenitor proliferation and survival resulting in limb muscle patterning defects. Transcriptome and functional analyses reveal that Osr1 + cells provide a critical pro-myogenic niche via the production of MCT specific extracellular matrix components and secreted signaling factors.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-017-01120-3

Cites

70 of 70 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Osr1 is expressed in limb mesenchymal cells associated with myogenic cells and labels MCT cells. a–e Osr1 expression was assessed by immunolabelling for GFP on Osr1 GCE/+ embryos at the indicated stages. Osr1+ cells are found interstitial to Lbx1+, Pax7+ and MyoD1+ myogenic progenitors and interstitial to developing myofibres labelled either for Myosin heavy chain (MyHC) or Laminin. Note that in some developing muscles Osr1+ cells are abundant, while being scarce in others. Boxed regions (numbered in a) are shown in the panels to the right of overview images and are magnifications of the area. f Osr1 expression was analysed by in situ hybridization to sections of muscleless limbs of E11.5 (left), 12.5 (middle) and 13.5 (right) Pax3 mutant embryos. The overall expression pattern of Osr1 is similar in limbs of Pax3 GFP/+ and Pax3 GFP/GFP embryos. Arrows highlight strong Osr1 expression observed in control and muscleless limbs. Boxed regions are shown in the panels to the right of overview images and are magnifications of the area. g Schematic depiction of limb Osr1+ cell isolation procedure and examples of FACS plots. h Expression of fibroblastic markers in freshly FACS-isolated Osr1+ cells subjected to cytospin. (n = 3). i Osr1+ cells cultured in growth medium maintained the expression of fibroblastic markers (n = 3). Insets in h, i are percentage of COL1+, PDGFRα+, Vimentin+, Pan-COL6+, αSMA+ and Tcf4+ cells among the Osr1+ cell population. Values represent mean ± s.e.m. N-numbers indicate biological replicates, i.e. samples from different specimen
Fig. 1 Osr1 is expressed in limb mesenchymal cells associated with myogenic cells and labels MCT cells. a–e Osr1 expression was assessed by immunolabelling for GFP on Osr1 GCE/+ embryos at the indicated stages. Osr1+ cells are found interstitial to Lbx1+, Pax7+ and MyoD1+ myogenic progenitors and interstitial to developing myofibres labelled either for Myosin heavy chain (MyHC) or Laminin. Note that in some developing muscles Osr1+ cells are abundant, while being scarce in others. Boxed regions (numbered in a) are shown in the panels to the right of overview images and are magnifications of the area. f Osr1 expression was analysed by in situ hybridization to sections of muscleless limbs of E11.5 (left), 12.5 (middle) and 13.5 (right) Pax3 mutant embryos. The overall expression pattern of Osr1 is similar in limbs of Pax3 GFP/+ and Pax3 GFP/GFP embryos. Arrows highlight strong Osr1 expression observed in control and muscleless limbs. Boxed regions are shown in the panels to the right of overview images and are magnifications of the area. g Schematic depiction of limb Osr1+ cell isolation procedure and examples of FACS plots. h Expression of fibroblastic markers in freshly FACS-isolated Osr1+ cells subjected to cytospin. (n = 3). i Osr1+ cells cultured in growth medium maintained the expression of fibroblastic markers (n = 3). Insets in h, i are percentage of COL1+, PDGFRα+, Vimentin+, Pan-COL6+, αSMA+ and Tcf4+ cells among the Osr1+ cell population. Values represent mean ± s.e.m. N-numbers indicate biological replicates, i.e. samples from different specimenCC BY · PubMed Central
Fig. 2 Osr1 and Tcf4 identify distinct and common MCT cells. a, b Osr1 expression was assessed by immunolabelling for GFP on E11.5 and E13.5 Osr1 GCE/+ embryos. Boxed regions are shown in the numbered panels below and are magnifications of the area. a At E11.5 Osr1 is expressed in limb mesenchyme at the level of the humerus condensation overlapping with Tcf4. Tcf4 is expressed towards the centre and Osr1 towards the periphery of the limb. b At E13.5 Osr1 is expressed in limb mesenchyme in the periphery and encompassing the biceps femoris (bf), gastrocnemius (gc), soleus (so), plantaris (pa), semimembranosus (sm), peroneus longus (pl), extensor digitorum longus (edl) and tibialis anterior (ta) muscles. Tcf4 is expressed in central areas of the limb, where it is exclusive in the flexor digitorum longus (fdl) muscle, and within and surrounding the edl and ta muscles. c E18.5 limb muscle interstitial cells were FACS-isolated as indicated and separated into Osr1-expressing and Osr1-negative (GFP+ and GFP−) populations. Cytospun cells were labelled for Tcf4 and PDGFRα. Quantification showing the percentages of PDGFRα+ and Tcf4+ cells in GFP+ or GFP− populations is shown below. Percentage of PDGFRα cells in all Tcf4 cells was counted in both GFP+ and GFP−populations (n = 3). Values represent mean ± s.e.m (n = 3). N-numbers indicate biological replicates, i.e. samples from different specimen
Fig. 2 Osr1 and Tcf4 identify distinct and common MCT cells. a, b Osr1 expression was assessed by immunolabelling for GFP on E11.5 and E13.5 Osr1 GCE/+ embryos. Boxed regions are shown in the numbered panels below and are magnifications of the area. a At E11.5 Osr1 is expressed in limb mesenchyme at the level of the humerus condensation overlapping with Tcf4. Tcf4 is expressed towards the centre and Osr1 towards the periphery of the limb. b At E13.5 Osr1 is expressed in limb mesenchyme in the periphery and encompassing the biceps femoris (bf), gastrocnemius (gc), soleus (so), plantaris (pa), semimembranosus (sm), peroneus longus (pl), extensor digitorum longus (edl) and tibialis anterior (ta) muscles. Tcf4 is expressed in central areas of the limb, where it is exclusive in the flexor digitorum longus (fdl) muscle, and within and surrounding the edl and ta muscles. c E18.5 limb muscle interstitial cells were FACS-isolated as indicated and separated into Osr1-expressing and Osr1-negative (GFP+ and GFP−) populations. Cytospun cells were labelled for Tcf4 and PDGFRα. Quantification showing the percentages of PDGFRα+ and Tcf4+ cells in GFP+ or GFP− populations is shown below. Percentage of PDGFRα cells in all Tcf4 cells was counted in both GFP+ and GFP−populations (n = 3). Values represent mean ± s.e.m (n = 3). N-numbers indicate biological replicates, i.e. samples from different specimenCC BY · PubMed Central
Fig. 3 Osr1+ cells are embryonic fibro-adipogenic progenitors. a Cultures of Osr1+ cells under fibrogenic, adipogenic, chondrogenic, osteogenic or myogenic conditions. Fibrogenic differentiation was assessed by COL1 immunolabelling, cells exhibited stretched myofibroblast morphology. Adipogenic differentiation was assessed by Oil Red O staining, chondrogenic and osteogenic differentiation was assessed by Alcian blue and Alizarin red staining, respectively and myogenic differentiation was tested by immunolabelling for Myod1 and MyHC. Osr1+ cells show fibrogenic and adipogenic differentiation, but no osteogenic or myogenic differentiation. GFP− FACS-sorted cells (Osr1−) containing osteo-chondrogenic and myogenic progenitors were used as controls (inserts). b Osr1 cell lineage tracing in E18.5 Osr1 GCE/+;R26R mTmG/+ embryos after Tamoxifen induction at E11.5. Membrane eGFP (mG) positive cells represent Osr1+ cell progeny. Schematic depiction of Osr1 GCE/+;R26R mTmG/+-based lineage tracing during development is shown above. Osr1+ progenitors give rise to muscle interstitial cells, dermis cells embedded in Collagen type I-rich matrix, and adipocytes immunolabelled for Fatty acid binding protein 4 (FABP4) in axillary and inguinal white fat pads. Ed = epidermis, der = dermis. c Osr1 cell lineage tracing in E18.5 Osr1 GCE/+;R26R mTmG/+ embryos after Tamoxifen induction at E11.5 as in b. Lineage contribution of Osr1 descendants (mG+) to PDGFRα and Tcf4 cells was analysed in the gastrocnemius and tibialis anterior muscles. Quantification is shown below (n = 3). Values represent mean ± s.e.m. N-numbers indicate biological replicates, i.e. samples from different specimen
Fig. 3 Osr1+ cells are embryonic fibro-adipogenic progenitors. a Cultures of Osr1+ cells under fibrogenic, adipogenic, chondrogenic, osteogenic or myogenic conditions. Fibrogenic differentiation was assessed by COL1 immunolabelling, cells exhibited stretched myofibroblast morphology. Adipogenic differentiation was assessed by Oil Red O staining, chondrogenic and osteogenic differentiation was assessed by Alcian blue and Alizarin red staining, respectively and myogenic differentiation was tested by immunolabelling for Myod1 and MyHC. Osr1+ cells show fibrogenic and adipogenic differentiation, but no osteogenic or myogenic differentiation. GFP− FACS-sorted cells (Osr1−) containing osteo-chondrogenic and myogenic progenitors were used as controls (inserts). b Osr1 cell lineage tracing in E18.5 Osr1 GCE/+;R26R mTmG/+ embryos after Tamoxifen induction at E11.5. Membrane eGFP (mG) positive cells represent Osr1+ cell progeny. Schematic depiction of Osr1 GCE/+;R26R mTmG/+-based lineage tracing during development is shown above. Osr1+ progenitors give rise to muscle interstitial cells, dermis cells embedded in Collagen type I-rich matrix, and adipocytes immunolabelled for Fatty acid binding protein 4 (FABP4) in axillary and inguinal white fat pads. Ed = epidermis, der = dermis. c Osr1 cell lineage tracing in E18.5 Osr1 GCE/+;R26R mTmG/+ embryos after Tamoxifen induction at E11.5 as in b. Lineage contribution of Osr1 descendants (mG+) to PDGFRα and Tcf4 cells was analysed in the gastrocnemius and tibialis anterior muscles. Quantification is shown below (n = 3). Values represent mean ± s.e.m. N-numbers indicate biological replicates, i.e. samples from different specimenCC BY · PubMed Central
Fig. 4 Developmental Osr1+ cells are a source for adult FAPs. a Osr1 is expressed in PDGFRα+ interstitial mesenchymal progenitors at birth (postnatal day P0). b Osr1 cell lineage tracing in adult (P84/12 week) Osr1 GCE/+;R26R LacZ/+ animals after Tamoxifen induction at P0. Osr1+ cell progeny is marked by immunolabelling for beta-Galactosidase (bGal). Perinatal Osr1+ cells give rise to interstitial PDGFRα+ FAPs. c Osr1 cell lineage tracing in adult (12 week) Osr1 GCE/+;R26 mTmG/+ animals after Tamoxifen induction at P0; Osr1 +/+;R26 mTmG/+ animals used as controls are shown left. FAPs (Sca1+, CD34+), satellite cells (SAT) and double-negaitve cells (DN) were FACS-isolated and analysed for mGFP expression. Only FAPs contained a clearly detectable mGFP+ population (n = 3). d mGFP+ and mGFP− FAPs isolated as in c were cytospun and analysed for PDGFRα and Tcf4 expression. Quantification is shown below (n = 3). e The contribution of p0 Osr1+ cells to muscle interstitial PDGFRα+ and Tcf4+ cells was quantified on sections of Osr1 GCE/+;R26 mTmG/+ animals in the indicated muscles. Quantification is shown below (n = 4). Values represent mean ± s.e.m. N-numbers indicate biological replicates, i.e. samples from different specimen
Fig. 4 Developmental Osr1+ cells are a source for adult FAPs. a Osr1 is expressed in PDGFRα+ interstitial mesenchymal progenitors at birth (postnatal day P0). b Osr1 cell lineage tracing in adult (P84/12 week) Osr1 GCE/+;R26R LacZ/+ animals after Tamoxifen induction at P0. Osr1+ cell progeny is marked by immunolabelling for beta-Galactosidase (bGal). Perinatal Osr1+ cells give rise to interstitial PDGFRα+ FAPs. c Osr1 cell lineage tracing in adult (12 week) Osr1 GCE/+;R26 mTmG/+ animals after Tamoxifen induction at P0; Osr1 +/+;R26 mTmG/+ animals used as controls are shown left. FAPs (Sca1+, CD34+), satellite cells (SAT) and double-negaitve cells (DN) were FACS-isolated and analysed for mGFP expression. Only FAPs contained a clearly detectable mGFP+ population (n = 3). d mGFP+ and mGFP− FAPs isolated as in c were cytospun and analysed for PDGFRα and Tcf4 expression. Quantification is shown below (n = 3). e The contribution of p0 Osr1+ cells to muscle interstitial PDGFRα+ and Tcf4+ cells was quantified on sections of Osr1 GCE/+;R26 mTmG/+ animals in the indicated muscles. Quantification is shown below (n = 4). Values represent mean ± s.e.m. N-numbers indicate biological replicates, i.e. samples from different specimenCC BY · PubMed Central
Fig. 5 Limb muscle patterning defects in Osr1-deficient embryos. a Muscle pattern in hindlimbs of E14.5 Osr1 +/+ and Osr1 GCE/GCE embryos assessed by whole limb immunolabelling for Myosin heavy chain (MyHC) followed by 3D reconstruction. Affected muscles are highlighted by false colours. Note truncations of several muscles. Scale bars: 100 μm. b Sections of E13.5 hindlimbs, where the Biceps femoris muscle is highlighted. Section planes are indicated in green muscles (a, bottom right) by the dashed lines. The distal truncated region of the B. femoris muscle is devoid of myogenic cells in Osr1 mutants highlighted with dashed lines. In the residual B. femoris muscle of Osr1 mutants, myogenic cells appear in disarray (see high magnifications). Analysis was done on serial sections of whole limbs to exclude section artefacts. c Ectopic Myod1+ myoblasts and MyHC+ myofibers between the Extensor digitorum longus (EDL) and Peroneus longus (PL) muscles in Osr1 mutants (yellow arrows). d Wholemount in situ hybridization on E13.5 Osr1 +/+ or Osr1 GCE/GCE embryos for myogenic markers Myod1 and Myog. Misshaped muscle primordia in limbs (white arrows), disarrayed myofibres in the latissimus dorsi muscle (yellow arrows) and ectopic myoblasts (red arrows) are observed in Osr1 mutants. e Immunolabelling for Lbx1 and Myod1 on E11.5 limb sections shows a decrease in the overall number of myogenic cells in proximal, dorsal and ventral muscle primordia in mutant compared to wt embryos (n = 3). f Reduced proliferation rate of Lbx1+ myogenic progenitors (dorsal: wt 38,6±2,3%, mut 30±1,8%; ventral: wt 41,1±1,3%, mut 29,6±1,0%) in E11.5 Osr1 mutants assessed by BrdU labelling (n = 4). (g) Increased apoptosis in myogenic cells in Osr1 mutants assessed by immunolabelling for cleaved (activated) Caspase 3 (c-Casp3) (n = 3). Error bars represent s.e.m. T-test: *=p < 0.05; **=p < 0.01; ***=p < 0.001. N-numbers indicate biological replicates, i.e. samples from different specimen
Fig. 5 Limb muscle patterning defects in Osr1-deficient embryos. a Muscle pattern in hindlimbs of E14.5 Osr1 +/+ and Osr1 GCE/GCE embryos assessed by whole limb immunolabelling for Myosin heavy chain (MyHC) followed by 3D reconstruction. Affected muscles are highlighted by false colours. Note truncations of several muscles. Scale bars: 100 μm. b Sections of E13.5 hindlimbs, where the Biceps femoris muscle is highlighted. Section planes are indicated in green muscles (a, bottom right) by the dashed lines. The distal truncated region of the B. femoris muscle is devoid of myogenic cells in Osr1 mutants highlighted with dashed lines. In the residual B. femoris muscle of Osr1 mutants, myogenic cells appear in disarray (see high magnifications). Analysis was done on serial sections of whole limbs to exclude section artefacts. c Ectopic Myod1+ myoblasts and MyHC+ myofibers between the Extensor digitorum longus (EDL) and Peroneus longus (PL) muscles in Osr1 mutants (yellow arrows). d Wholemount in situ hybridization on E13.5 Osr1 +/+ or Osr1 GCE/GCE embryos for myogenic markers Myod1 and Myog. Misshaped muscle primordia in limbs (white arrows), disarrayed myofibres in the latissimus dorsi muscle (yellow arrows) and ectopic myoblasts (red arrows) are observed in Osr1 mutants. e Immunolabelling for Lbx1 and Myod1 on E11.5 limb sections shows a decrease in the overall number of myogenic cells in proximal, dorsal and ventral muscle primordia in mutant compared to wt embryos (n = 3). f Reduced proliferation rate of Lbx1+ myogenic progenitors (dorsal: wt 38,6±2,3%, mut 30±1,8%; ventral: wt 41,1±1,3%, mut 29,6±1,0%) in E11.5 Osr1 mutants assessed by BrdU labelling (n = 4). (g) Increased apoptosis in myogenic cells in Osr1 mutants assessed by immunolabelling for cleaved (activated) Caspase 3 (c-Casp3) (n = 3). Error bars represent s.e.m. T-test: *=p < 0.05; **=p < 0.01; ***=p < 0.001. N-numbers indicate biological replicates, i.e. samples from different specimenCC BY · PubMed Central
Fig. 6 Osr1 controls ECM gene expression in a bimodal way and is required to prevent ectopic cartilage / tendon gene expression. a Volcano plot depiction of transcriptome analysis of FACS-sorted Osr1+ cells from limbs of E13.5 Osr1 GCE/+ or Osr1 GCE/GCE embryos shows differentially expressed (DE) genes between Osr1 GCE/+ and Osr1 GCE/GCE limb cells. 511 DE genes were identified with a false discovery rate of 0,05 that showed a log2 fold change over 1,2 or below 0,8 and a Benjamini-Hochberg adjusted p-value (padj) < 0,1. b GO analysis of all DE genes for “cellular component” showed enrichment for the indicated terms. c Heatmap depiction of all genes belonging to the term “extracellular matrix” (ECM). Selected ECM genes are indicated. d Bar graph plot for genes selected from all DE genes for their cartilage and/or tendon- specific expression pattern in embryo; note that all cartilage/tendon genes are upregulated in Osr1 mutants. e Confirmation of upregulation of Runx2, Sox5 and Sox9 (cartilage genes) and Scx, Mkx and Tnmd (tendon genes) in E11.5 and E13.5 Osr1 deficient cells by RT-qPCR (n = 4). f Chondrogenic culture of Osr1GCE/+ and Osr1GCE/GCE cells. Chondrogenic matrix is stained with Alcian blue, histomorphometric quantification is shown on the right. (n = 3). Error bars represent log2 fold change standard error (ifcSE) estimated by DESeq2 in d and s.e.m. in e, f. T-test: *=p < 0.05; **=p < 0.01; ***=p < 0.001. N-numbers indicate biological replicates, i.e. samples from different specimen
Fig. 6 Osr1 controls ECM gene expression in a bimodal way and is required to prevent ectopic cartilage / tendon gene expression. a Volcano plot depiction of transcriptome analysis of FACS-sorted Osr1+ cells from limbs of E13.5 Osr1 GCE/+ or Osr1 GCE/GCE embryos shows differentially expressed (DE) genes between Osr1 GCE/+ and Osr1 GCE/GCE limb cells. 511 DE genes were identified with a false discovery rate of 0,05 that showed a log2 fold change over 1,2 or below 0,8 and a Benjamini-Hochberg adjusted p-value (padj) < 0,1. b GO analysis of all DE genes for “cellular component” showed enrichment for the indicated terms. c Heatmap depiction of all genes belonging to the term “extracellular matrix” (ECM). Selected ECM genes are indicated. d Bar graph plot for genes selected from all DE genes for their cartilage and/or tendon- specific expression pattern in embryo; note that all cartilage/tendon genes are upregulated in Osr1 mutants. e Confirmation of upregulation of Runx2, Sox5 and Sox9 (cartilage genes) and Scx, Mkx and Tnmd (tendon genes) in E11.5 and E13.5 Osr1 deficient cells by RT-qPCR (n = 4). f Chondrogenic culture of Osr1GCE/+ and Osr1GCE/GCE cells. Chondrogenic matrix is stained with Alcian blue, histomorphometric quantification is shown on the right. (n = 3). Error bars represent log2 fold change standard error (ifcSE) estimated by DESeq2 in d and s.e.m. in e, f. T-test: *=p < 0.05; **=p < 0.01; ***=p < 0.001. N-numbers indicate biological replicates, i.e. samples from different specimenCC BY · PubMed Central
Fig. 7 Osr1 is required for muscle connective tissue ECM gene expression. a Bar graph plot of genes selected from all DE genes by their expression associated with muscle connective tissue; most of the genes belong to the downregulated cluster in (Fig. 6c). b Confirmation of downregulation of selected MCT-ECM genes in E11.5 and E13.5 Osr1 deficient cells by RT-qPCR (n = 4). c Immunolabelling for MyHC and COL6 shows reduced abundance of COL6 in Osr1 mutants. d Transduction of E13.5 MEFs with lentiviral particles causes mild overexpression of Osr1. e Lentiviral overexpression of Osr1 causes upregulation of Col6a1, Col6a3 and Lum genes. f Chromatin immunoprecipitation of putative Osr1 binding sites at the Col6a1 and Col6a3 loci. Above: schematic representation of the loci; positions of Osr1 binding sites and PCR primers relative to exon 1 of the Col6a1 and Col6a3 genes are indicated. Below: representative gel pictures of ChIP vs. input are shown left, confirmation of binding site pulldown via RT-qPCR (n = 3) are shown right. Bs: putative binding site, No Bs: control region. Size marker: 100 base pair ladder; band sizes are indicated in base pairs. Error bars represent log2 fold change standard error (ifcSE) estimated by DESeq2 in a and s.e.m. in (b, d, e, f). T-test: *=p < 0.05; **=p < 0.01; ***=p < 0.001. N-numbers indicate biological replicates, i.e. samples from different specimen in b or independent assays in d, e, f
Fig. 7 Osr1 is required for muscle connective tissue ECM gene expression. a Bar graph plot of genes selected from all DE genes by their expression associated with muscle connective tissue; most of the genes belong to the downregulated cluster in (Fig. 6c). b Confirmation of downregulation of selected MCT-ECM genes in E11.5 and E13.5 Osr1 deficient cells by RT-qPCR (n = 4). c Immunolabelling for MyHC and COL6 shows reduced abundance of COL6 in Osr1 mutants. d Transduction of E13.5 MEFs with lentiviral particles causes mild overexpression of Osr1. e Lentiviral overexpression of Osr1 causes upregulation of Col6a1, Col6a3 and Lum genes. f Chromatin immunoprecipitation of putative Osr1 binding sites at the Col6a1 and Col6a3 loci. Above: schematic representation of the loci; positions of Osr1 binding sites and PCR primers relative to exon 1 of the Col6a1 and Col6a3 genes are indicated. Below: representative gel pictures of ChIP vs. input are shown left, confirmation of binding site pulldown via RT-qPCR (n = 3) are shown right. Bs: putative binding site, No Bs: control region. Size marker: 100 base pair ladder; band sizes are indicated in base pairs. Error bars represent log2 fold change standard error (ifcSE) estimated by DESeq2 in a and s.e.m. in (b, d, e, f). T-test: *=p < 0.05; **=p < 0.01; ***=p < 0.001. N-numbers indicate biological replicates, i.e. samples from different specimen in b or independent assays in d, e, fCC BY · PubMed Central
Fig. 8 Osr1 cells are a source or growth factor signalling and Osr1 directly controls Cxcl12 expression. a Gene ontology (GO) analysis for “biological process” using all deregulated (DE) genes (Osr1 GCE/+ vs. Osr1 GCE/GCE cells) showed significant enrichment for the indicated terms. b KEGG pathway analysis of downregulated genes. c Heatmap depiction of all non-redundant DE genes contained in the GO terms shown in c collectively termed “immune processes”. Several genes for signalling molecules from chemokine families appear downregulated in Osr1 GCE/GCE limb cells. d Deregulation of secreted signalling molecules selected from all DE genes for their previously demonstrated role in myogenesis. e Confirmation of downregulation of Cxcl12 and Bmp4 in Osr1-deficient cells isolated at E11.5 and E13.5 by RT-qPCR (n = 5). f Upregulation of Cxcl12 upon lentiviral Osr1 overexpression. g Chromatin immunoprecipitation (ChIP) for a putative Cxcl12 enhancer. Representative gel pictures of ChIP vs. input are shown below schematic representation of the locus, confirmation of binding site pulldown via RT-qPCR (n = 3) shown right. Bs: putative binding site, No Bs: control region. DNAse HSS: DNAseI hypersensitive regions according to UCSC. Size marker: 100 base pair ladder; band sizes are indicated in base pairs. Error bars represent log2 fold change standard error (ifcSE) estimated by DESeq2 in d and s.e.m. in e, f, g. T-test: *=p < 0.05; **=p < 0.01. N-numbers indicate biological replicates, i.e. samples from different specimen in e or independent assays in f, g
Fig. 8 Osr1 cells are a source or growth factor signalling and Osr1 directly controls Cxcl12 expression. a Gene ontology (GO) analysis for “biological process” using all deregulated (DE) genes (Osr1 GCE/+ vs. Osr1 GCE/GCE cells) showed significant enrichment for the indicated terms. b KEGG pathway analysis of downregulated genes. c Heatmap depiction of all non-redundant DE genes contained in the GO terms shown in c collectively termed “immune processes”. Several genes for signalling molecules from chemokine families appear downregulated in Osr1 GCE/GCE limb cells. d Deregulation of secreted signalling molecules selected from all DE genes for their previously demonstrated role in myogenesis. e Confirmation of downregulation of Cxcl12 and Bmp4 in Osr1-deficient cells isolated at E11.5 and E13.5 by RT-qPCR (n = 5). f Upregulation of Cxcl12 upon lentiviral Osr1 overexpression. g Chromatin immunoprecipitation (ChIP) for a putative Cxcl12 enhancer. Representative gel pictures of ChIP vs. input are shown below schematic representation of the locus, confirmation of binding site pulldown via RT-qPCR (n = 3) shown right. Bs: putative binding site, No Bs: control region. DNAse HSS: DNAseI hypersensitive regions according to UCSC. Size marker: 100 base pair ladder; band sizes are indicated in base pairs. Error bars represent log2 fold change standard error (ifcSE) estimated by DESeq2 in d and s.e.m. in e, f, g. T-test: *=p < 0.05; **=p < 0.01. N-numbers indicate biological replicates, i.e. samples from different specimen in e or independent assays in f, gCC BY · PubMed Central
Fig. 9 Osr1-deficiency impairs the myogenic niche in developing limbs. a Decreased abundance of COL6 and FN (Fibronectin) in proximal (inserts 1 and 3) and dorsal (inserts 2 and 4) muscle primordia of Osr1-deficient E11.5 limbs. Boxed regions are shown in the numbered panels to the right and are magnifications of the area. b Reduced abundance of interstitial FN and disarrangement of COL14 in E13.5 Osr1 GCE/GCE limb muscles as compared to wild-type littermate controls. c Extracellular matrix (ECM) produced by Osr1GCE/+ cells, but not ECM produced by Osr1GCE/GCE cells supports myoblast proliferation (n = 3). d E11.5 Col6a1 −/− embryos show a decrease in myogenic progenitor numbers (n = 3). e Transwell assay shows a beneficial effect of E13.5 Osr1GCE/+ embryonic FAPs (eFAPs) but not Osr1GCE/GCE eFAPs on myogenesis. Transwell culture without eFAPs was used as control (n = 3). f Cxcr4 −/− embryos show muscle defects overlapping with Osr1GCE/GCE embryos. g Sections of Cxcr4 +/+ and Cxcr4 −/− embryos show almost complete reduction of the biceps femoris anterior head and hypoplasia of the biceps femoris accessory head. h Decreased phosphorylated ERK (pERK) and (i) CyclinD1 in myogenic Lbx1+ cells in E11.5 Osr1 mutants (n = 3). j Schematic model of Osr1+ cell function. Osr1+ cells (green) produce chemokines as Cxcl12 and a specific extracellular matrix (ECM) supporting myoblast proliferation and survival involving pERK signaling. Cxcl12 in addition likely provides local migratory cues ensuring correct spatial distribution of myoblasts as a prerequisite for muscle patterning. k Schematic model of limb muscle connective tissue compartmentalization. Specific transcription factors (Osr1 and Tcf4 are shown as examples) are expressed regionally in the limb bud with areas of overlap creating a regionalized code that likely determines the composition of the local niche. Error bars represent s.e.m. T-test: *=p < 0.05; **=p < 0.01; ***=p < 0.001. N-numbers indicate biological replicates, i.e. samples from different specimen in d, h, i or independent assays in c, e
Fig. 9 Osr1-deficiency impairs the myogenic niche in developing limbs. a Decreased abundance of COL6 and FN (Fibronectin) in proximal (inserts 1 and 3) and dorsal (inserts 2 and 4) muscle primordia of Osr1-deficient E11.5 limbs. Boxed regions are shown in the numbered panels to the right and are magnifications of the area. b Reduced abundance of interstitial FN and disarrangement of COL14 in E13.5 Osr1 GCE/GCE limb muscles as compared to wild-type littermate controls. c Extracellular matrix (ECM) produced by Osr1GCE/+ cells, but not ECM produced by Osr1GCE/GCE cells supports myoblast proliferation (n = 3). d E11.5 Col6a1 −/− embryos show a decrease in myogenic progenitor numbers (n = 3). e Transwell assay shows a beneficial effect of E13.5 Osr1GCE/+ embryonic FAPs (eFAPs) but not Osr1GCE/GCE eFAPs on myogenesis. Transwell culture without eFAPs was used as control (n = 3). f Cxcr4 −/− embryos show muscle defects overlapping with Osr1GCE/GCE embryos. g Sections of Cxcr4 +/+ and Cxcr4 −/− embryos show almost complete reduction of the biceps femoris anterior head and hypoplasia of the biceps femoris accessory head. h Decreased phosphorylated ERK (pERK) and (i) CyclinD1 in myogenic Lbx1+ cells in E11.5 Osr1 mutants (n = 3). j Schematic model of Osr1+ cell function. Osr1+ cells (green) produce chemokines as Cxcl12 and a specific extracellular matrix (ECM) supporting myoblast proliferation and survival involving pERK signaling. Cxcl12 in addition likely provides local migratory cues ensuring correct spatial distribution of myoblasts as a prerequisite for muscle patterning. k Schematic model of limb muscle connective tissue compartmentalization. Specific transcription factors (Osr1 and Tcf4 are shown as examples) are expressed regionally in the limb bud with areas of overlap creating a regionalized code that likely determines the composition of the local niche. Error bars represent s.e.m. T-test: *=p < 0.05; **=p < 0.01; ***=p < 0.001. N-numbers indicate biological replicates, i.e. samples from different specimen in d, h, i or independent assays in c, eCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 70 references

Cited by

See all 126

Metadata

Authors
Vallecillo-García, P., Orgeur, M., vom Hofe-Schneider, S., Stumm, J., Kappert, V., Ibrahim, D. M., Börno, S. T., Hayashi, S., Relaix, F., Hildebrandt, K., Sengle, G., Koch, M., Timmermann, B., Marazzi, G., Sassoon, D. A., Duprez, D., & Stricker, S.
Affiliations
  • Max Planck Institute for Molecular Genetics (DE)
  • Centre National de la Recherche Scientifique (FR)
  • Inserm (FR)
  • University of Cologne (DE)
  • Sorbonne Université (FR)
Corresponding author
Stricker, Sigmar
Venue
Nature Communications
Published
2017-10-31
Volume
8
Issue
1
Pages
1218-1218
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2766765760
Cited by
126
References
70
Citations by year
2026: 10 · 2025: 8 · 2024: 23 · 2023: 14 · 2022: 16 · 2021: 16 · 2020: 15 · 2019: 10 · 2018: 14
FWCI
4.33
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Kölner Universitäts PublikationsServer (Universität zu Köln) (publishedVersion)
  • HAL (submittedVersion, cc-by)
  • HAL (submittedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
  • MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
  • Refubium (Universitätsbibliothek der Freien Universität Berlin) (submittedVersion, cc-by)
  • Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver (cc-by)
Funders
  • Deutsche Forschungsgemeinschaft (GK 1631)
  • Fondation pour la Recherche Médicale (FRM DEQ20140329500, FDT20150532272, DEQ20140329500)
  • Medizinischen Hochschule Hannover
  • Freie Universität Berlin
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
Keywords
OSR1, fibro-adipogenic progenitors, myogenesis, limb muscle development, muscle patterning, myogenic progenitor cells, lineage tracing, extracellular matrix, muscle regeneration, adipogenesis, fibrogenesis
MeSH terms
Transcription Factor 4, Aging, Animals, Connective Tissue, Embryo, Mammalian, Extremities, Gene Expression Regulation, Transcription Factors, Signal Transduction, Extracellular Matrix Proteins, Body Patterning, Muscle Development, Myoblasts, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Odd skipped-related 1 identifies a population of embryonic fibro-adipogenic progenitors regulating myogenesis during limb development. https://app.cochat.ai/papers/10.1038/s41467-017-01120-3
The paper
Vallecillo-García, P., Orgeur, M., vom Hofe-Schneider, S., Stumm, J., Kappert, V., Ibrahim, D. M., Börno, S. T., Hayashi, S., Relaix, F., Hildebrandt, K., Sengle, G., Koch, M., Timmermann, B., Marazzi, G., Sassoon, D. A., Duprez, D., & Stricker, S. (2017). Odd skipped-related 1 identifies a population of embryonic fibro-adipogenic progenitors regulating myogenesis during limb development. Nature Communications. https://doi.org/10.1038/s41467-017-01120-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.